Merck, Bristol Myers Squibb, the U.S. Chamber of Commerce and PhRMA filed separate lawsuits against the provision last month.

Johnson & Johnson sued the Biden administration over Medicare’s new powers to slash drug prices, making it the third pharmaceutical company to challenge the controversial provision of the Inflation Reduction Act.

  • Coreidan@lemmy.worldEnglish
    7·
    1 year ago

    Oh no those poor billionaires! They won’t be able to rob people of their savings nearly as effectively. That might even slow down the purchase of their next yacht. How horrible!